- IceCure Medical
- IceCure Medical, Inc. develops and commercializes minimally invasive cryoablation for applications in women’s health. Our first technology, IceSense3, offers a minimally invasive, in-office treatment for the treatment of symptomatic breast fibroadenoma. IceSense3 is an attractive alternative to the current standard treatment of open surgical excision. The IceSense3 cryoprobe is inserted under ultrasound guidance while the system uses liquid nitrogen for rapid freezing. Our advanced cryoablation probe design provides a treatment zone that is easily customized to match the size and shape of the targeted fibroadenoma. The IceSense3 system is a viable treatment option because it is safe and effective and can be performed in as little as 5-15 minutes. Physicians are pleased with the system because the learning curve is short and the procedure spares the ductal system.